{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:30:16Z","timestamp":1780453816576,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03449-8","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T07:01:49Z","timestamp":1728889309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluating the efficacy of 8 non-invasive models in predicting MASLD and progression: a prospective study"],"prefix":"10.1186","volume":"24","author":[{"given":"Aruhan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meishan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"3449_CR1","doi-asserted-by":"publisher","unstructured":"Ajmera V, Cepin S, Tesfai K, et al. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol Published Online November. 2022;S0168827822033025. https:\/\/doi.org\/10.1016\/j.jhep.2022.11.010.","DOI":"10.1016\/j.jhep.2022.11.010"},{"issue":"7","key":"3449_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metabol. 2022;34(7):969\u2013e9772. https:\/\/doi.org\/10.1016\/j.cmet.2022.05.003.","journal-title":"Cell Metabol"},{"key":"3449_CR3","doi-asserted-by":"publisher","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol Published Online June 2023:S016882782300418X https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003","DOI":"10.1016\/j.jhep.2023.06.003"},{"issue":"5","key":"3449_CR4","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jhep.2022.07.004","volume":"77","author":"AM Allen","year":"2022","unstructured":"Allen AM, Therneau TM, Ahmed OT, et al. Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design. J Hepatol. 2022;77(5):1237\u201345. https:\/\/doi.org\/10.1016\/j.jhep.2022.07.004.","journal-title":"J Hepatol"},{"issue":"4","key":"3449_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","volume":"23","author":"DJH Tan","year":"2022","unstructured":"Tan DJH. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. Lancet Oncol. 2022;23(4):521\u201330. https:\/\/doi.org\/10.1016\/S1470-2045(22)00078-X.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3449_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","volume":"15","author":"BA Neuschwander-Tetri","year":"2017","unstructured":"Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017;15(1):45. https:\/\/doi.org\/10.1186\/s12916-017-0806-8.","journal-title":"BMC Med"},{"key":"3449_CR7","doi-asserted-by":"crossref","unstructured":"Bianco C, Jamialahmadi O, Pelusi S, et al. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.J Hepatol. 2021;74(4):775-782. doi:10.1016\/j.jhep.2020.11.024","DOI":"10.1016\/j.jhep.2020.11.024"},{"key":"3449_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jhep.2014.11.034","volume":"62","author":"S McPherson","year":"2015","unstructured":"McPherson S. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2015;62:8.","journal-title":"J Hepatol"},{"issue":"3","key":"3449_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","volume":"59","author":"R Pais","year":"2013","unstructured":"Pais R, Charlotte F, Fedchuk L, et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol. 2013;59(3):550\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2013.04.027.","journal-title":"J Hepatol"},{"issue":"5","key":"3449_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/gutjnl-2021-324264","volume":"71","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Munaganuru N, Jung J, et al. Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. Gut. 2022;71(5):983\u201390. https:\/\/doi.org\/10.1136\/gutjnl-2021-324264.","journal-title":"Gut"},{"issue":"2","key":"3449_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol. 2018;68(2):305\u201315. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.013.","journal-title":"J Hepatol"},{"key":"3449_CR12","doi-asserted-by":"publisher","unstructured":"Yang A, Zhu X, Zhang L, et al. Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study. Hepatol Int Published Online July. 2022;12. https:\/\/doi.org\/10.1007\/s12072-022-10355-2.","DOI":"10.1007\/s12072-022-10355-2"},{"issue":"3","key":"3449_CR13","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1148\/radiol.2017161228","volume":"284","author":"JP K\u00fchn","year":"2017","unstructured":"K\u00fchn JP, Meffert P, Heske C, et al. Prevalence of fatty liver disease and hepatic Iron overload in a northeastern German Population by using quantitative MR Imaging. Radiology. 2017;284(3):706\u201316. https:\/\/doi.org\/10.1148\/radiol.2017161228.","journal-title":"Radiology"},{"issue":"19","key":"3449_CR14","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486\u201397. https:\/\/doi.org\/10.1001\/jama.285.19.2486.","journal-title":"JAMA"},{"issue":"1","key":"3449_CR15","doi-asserted-by":"publisher","first-page":"e002362","DOI":"10.1136\/bmjdrc-2021-002362","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang J, Xu Q, Lai F, et al. Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults. BMJ Open Diab Res Care. 2021;9(1):e002362. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002362.","journal-title":"BMJ Open Diab Res Care"},{"issue":"13","key":"3449_CR16","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jacc.2018.08.1037","volume":"72","author":"CJ Lavie","year":"2018","unstructured":"Lavie CJ, Laddu D, Arena R, Ortega FB, Alpert MA, Kushner RF. Healthy Weight and Obesity Prevention: JACC Health Promotion Series. J Am Coll Cardiol. 2018;72(13):1506\u201331. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1037.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3449_CR17","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u2013835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323.","journal-title":"Hepatology"},{"key":"3449_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2020.575843","volume":"11","author":"A Dennis","year":"2021","unstructured":"Dennis A. Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis. Front Endocrinol. 2021;11:10.","journal-title":"Front Endocrinol"},{"issue":"4","key":"3449_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020;5(4):362\u201373. https:\/\/doi.org\/10.1016\/S2468-1253(19)30383-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3449_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. https:\/\/doi.org\/10.1186\/1471-230X-6-33.","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"3449_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138. https:\/\/doi.org\/10.1016\/j.dld.2009.08.002.","journal-title":"Dig Liver Dis"},{"issue":"21","key":"3449_CR22","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.21037\/atm-20-2951","volume":"8","author":"S Jeong","year":"2020","unstructured":"Jeong S, Kim K, Chang J, et al. Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance. Ann Transl Med. 2020;8(21):1414. https:\/\/doi.org\/10.21037\/atm-20-2951.","journal-title":"Ann Transl Med"},{"key":"3449_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"HS Kahn","year":"2005","unstructured":"Kahn HS. The lipid accumulation product performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26. https:\/\/doi.org\/10.1186\/1471-2261-5-26.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5\u20136","key":"3449_CR24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/07853890.2013.801275","volume":"45","author":"S Sandboge","year":"2013","unstructured":"Sandboge S, Per\u00e4l\u00e4 MM, Salonen MK, et al. Early growth and non-alcoholic fatty liver disease in adulthood-the NAFLD liver fat score and equation applied on the Helsinki Birth Cohort Study. Ann Med. 2013;45(5\u20136):430\u20137. https:\/\/doi.org\/10.3109\/07853890.2013.801275.","journal-title":"Ann Med"},{"issue":"6","key":"3449_CR25","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","volume":"118","author":"V Ratziu","year":"2000","unstructured":"Ratziu V, Giral P, Charlotte F, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000;118(6):1117\u201323. https:\/\/doi.org\/10.1016\/S0016-5085(00)70364-7.","journal-title":"Gastroenterology"},{"issue":"1","key":"3449_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41588-018-0271-0","volume":"51","author":"R Moore","year":"2019","unstructured":"Moore R, Casale FP, Jan Bonder M, et al. A linear mixed-model approach to study multivariate gene-environment interactions. Nat Genet. 2019;51(1):180\u20136. https:\/\/doi.org\/10.1038\/s41588-018-0271-0.","journal-title":"Nat Genet"},{"issue":"1","key":"3449_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol. 2022;18(1):55\u201366. https:\/\/doi.org\/10.1038\/s41574-021-00584-0.","journal-title":"Nat Rev Endocrinol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03449-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T07:03:14Z","timestamp":1728889394000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03449-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3449"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03449-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}